World's Best Scientists 2026 revealed!
Arnaud Didierlaurent

Arnaud Didierlaurent

D-Index & Metrics

Immunology

D-Index
44
Citations
10018
World Ranking
4757
National Ranking
103

Arnaud Didierlaurent publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arnaud Didierlaurent sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 103 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arnaud Didierlaurent D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arnaud Didierlaurent sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Arnaud Didierlaurent is affiliated with the University of Geneva in Switzerland. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with a significant portion dedicated to Infectious Diseases and Immunology.

The scientist's work spans several subfields of study including Infectious Diseases, Immunology, Epidemiology, Neurology, and Health. Their main research topics center on SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, immunotherapy and immune responses, vaccine coverage and hesitancy, long-term effects of COVID-19, immune responses and vaccinations, and immune response and inflammation.

Arnaud Didierlaurent has published extensively in various scientific journals. Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Frontiers in Immunology
  • Clinical Microbiology and Infection
  • Science Translational Medicine

Key papers authored or co-authored by Didierlaurent include:

  • "Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study" (2021), Clinical Microbiology and Infection
  • "Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines" (2020), Vaccine
  • "Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study" (2021), Clinical Infectious Diseases
  • "Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data" (2021), Vaccine
  • "Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs" (2022), Nature Communications

Arnaud Didierlaurent frequently collaborates with notable co-authors, including:

  • Christiane S. Eberhardt
  • Claire-Anne Siegrist
  • Benjamin Meyer
  • Laurent Kaiser
  • Isabella Eckerle

Best Publications

  • AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity.

    Arnaud M. Didierlaurent;Sandra Morel;Laurence Lockman;Sandra L. Giannini

  • Correlates of adjuvanticity: A review on adjuvants in licensed vaccines.

    Giuseppe Del Giudice;Rino Rappuoli;Arnaud M. Didierlaurent

  • A critical function for CD200 in lung immune homeostasis and the severity of influenza infection

    Robert J Snelgrove;John Goulding;Arnaud M Didierlaurent;Daphne Lyonga

  • Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity.

    Sandra Morel;Arnaud Didierlaurent;Patricia Bourguignon;Sophie Delhaye

  • The how’s and what’s of vaccine reactogenicity

    Caroline Hervé;Béatrice Laupèze;Giuseppe Del Giudice;Arnaud M. Didierlaurent

  • Adjuvant system AS01: helping to overcome the challenges of modern vaccines

    Unknown

  • Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.

    Arnaud Didierlaurent;John Goulding;Seema Patel;Robert Snelgrove

  • Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

    Nathalie Garçon;David W Vaughn;Arnaud M Didierlaurent

  • Flagellin Promotes Myeloid Differentiation Factor 88-Dependent Development of Th2-Type Response

    Arnaud Didierlaurent;Isabel Ferrero;Luc A. Otten;Bertrand Dubois

  • Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells

    Arnaud M. Didierlaurent;Catherine Collignon;Patricia Bourguignon;Sandrine Wouters

  • Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity.

    Margherita Coccia;Catherine Collignon;Caroline Hervé;Aurélie Chalon

  • An antiinflammatory role for IKKβ through the inhibition of "classical" macrophage activation

    Carol Ho Yan Fong;Magali Bebien;Arnaud Didierlaurent;Ruth Nebauer

  • Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide.

    Arnaud Didierlaurent;Brian Brissoni;Dominique Velin;Natalia Aebi

  • Role of Toll-like receptors in costimulating cytotoxic T cell responses.

    Katrin Schwarz;Tazio Storni;Vania Manolova;Arnaud Didierlaurent

  • How the gut senses its content.

    Arnaud Didierlaurent;Jean-Claude Sirard;Jean-Pierre Kraehenbuhl;Marian R. Neutra

  • Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach.

    Nathalie Garçon;Sandra Morel;Arnaud Didierlaurent;Dominique Descamps

  • Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.

    Paul Henri Lambert;Donna M. Ambrosino;Svein R. Andersen;Ralph S. Baric

  • Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans

    Wivine Burny;Andrea Callegaro;Viviane Bechtold;Frédéric Clement

  • Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs

    Unknown

  • The Generation of Mature, Single-Positive Thymocytes In Vivo Is Dysregulated by CD69 Blockade or Overexpression

    Toshinori Nakayama;Deborah J. Kasprowicz;Masakatsu Yamashita;Lisa A. Schubert

  • Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study.

    Arnaud G. L'Huillier;Benjamin Meyer;Diego O. Andrey;Isabelle Arm-Vernez

  • The impact of successive infections on the lung microenvironment.

    Arnaud Didierlaurent;John Goulding;Tracy Hussell

Frequent Co-Authors

Jean-Claude Sirard
Jean-Claude Sirard Institut Pasteur
Tracy Hussell
Tracy Hussell University of Manchester
Jean-Pierre Kraehenbuhl
Jean-Pierre Kraehenbuhl University of Lausanne
Bart N. Lambrecht
Bart N. Lambrecht Ghent University
Shizuo Akira
Shizuo Akira Osaka University
Satoshi Uematsu
Satoshi Uematsu Osaka Metropolitan University
Haruhiko Koseki
Haruhiko Koseki RIKEN Center for Integrative Medical Sciences
Toby Lawrence
Toby Lawrence King's College London
Ralf Wagner
Ralf Wagner University of Regensburg
Age K. Smilde
Age K. Smilde University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your expertise through complementary nursing degrees can open diverse career paths. Many professionals explore the dnp salary by specialty as a motivating factor, since salary prospects often vary based on specialization and location.

Nurses aiming to advance their clinical impact might consider bridge programs such as the fnp to acnp bridge program online, which enable transitions from Family Nurse Practitioner roles to Acute Care Nurse Practitioner specialties with flexibility.

Accelerated pathways are popular for those looking to quickly enter the field or climb the professional ladder. Several institutions offer accelerated np program options designed to fast-track nurse practitioner credentials online.

For individuals without a nursing background but interested in healthcare, online accelerated nursing programs for non nurses provide a gateway to start a nursing career, which can later complement immunology-related roles.

Best Scientists Citing Arnaud Didierlaurent

Trending Scientists

Recently Published Articles